Gary H. Lyman, MD, MPH

Articles by Gary H. Lyman, MD, MPH

Creating Value-Based Metrics for Cancer Care: A Stakeholder-Informed, Evidence-Driven Approach

ByScott D. Ramsey, MD, PhD,Gary H. Lyman, MD, MPH

April 16th 2015

Short-Term Costs Associated With Primary Prophylactic G-CSF Use During Chemotherapy

BySuja S. Rajan, MHA, MS, PhD,William R. Carpenter, MHA, PhD,Sally C. Stearns, PhD,Gary H. Lyman, MD, MPH

February 13th 2013

Granulocyte colony-stimulating factor therapy reduces hospitalizations and improves chemotherapy administration in elderly breast cancer patients, but increases overall Medicare costs during first year of therapy.

Latest Updated Articles

Creating Value-Based Metrics for Cancer Care: A Stakeholder-Informed, Evidence-Driven Approach
Published: April 16th 2015 | Updated:
Short-Term Costs Associated With Primary Prophylactic G-CSF Use During Chemotherapy
Published: February 13th 2013 | Updated:

Gary H. Lyman, MD, MPH

Articles by Gary H. Lyman, MD, MPH

Creating Value-Based Metrics for Cancer Care: A Stakeholder-Informed, Evidence-Driven Approach

Short-Term Costs Associated With Primary Prophylactic G-CSF Use During Chemotherapy

Latest Updated Articles

Trending on AJMC

FDA Approves Sibeprenlimab for Immunoglobulin A Nephropathy

Patients Face New Care Complexities as DTC Options Expand

Expiring ACA Subsidies and CMS Payment Models Raise Costs for Consumers and Employers

Louisiana Delivers Innovative Cancer Treatments, but Ensuring Access Is a Work in Progress

Ocrelizumab Leads to Lower Hospitalization Rates Compared to Rituximab in MS